Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Longeveron Inc
(NQ:
LGVN
)
2.190
-0.020 (-0.90%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Oct 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Longeveron Inc
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
April 08, 2024
It's time to start the trading week with a breakdown of the biggest pre-market stock movers worth watching on Monday morning!
Via
InvestorPlace
Why Esperion Therapeutics Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket
April 08, 2024
Shares of Esperion Therapeutics, Inc. (NASDAQ: ESPR) shares rose sharply during today’s pre-market trading after the company presented new data from CLEAR outcomes at ACC.24 highlighting value of...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
April 05, 2024
Via
Benzinga
Recap: Longeveron Q4 Earnings
February 27, 2024
Via
Benzinga
Earnings Scheduled For February 27, 2024
February 27, 2024
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report quarterly loss at $0.07 per share on revenue of $100.49 million.
Via
Benzinga
Earnings Preview For Longeveron
February 26, 2024
Via
Benzinga
Five Significant Strides Made in Alzheimer’s Research in 2023
January 05, 2024
Via
Investor Brand Network
Longeveron Inc. (NASDAQ: LGVN) Discusses 2023 Progress and 2024 Plans in Corporate Update
March 28, 2024
Via
Investor Brand Network
Why RH Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
March 28, 2024
Shares of RH (NYSE: RH) rose sharply in today’s pre-market trading following the release of quarterly results.
Via
Benzinga
Researchers Link Type 2 Diabetes to Heightened Alzheimer’s Risk
March 27, 2024
Via
Investor Brand Network
12 Health Care Stocks Moving In Wednesday's Intraday Session
March 20, 2024
Via
Benzinga
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Board Approves 1-for-10 Reverse Stock Split
March 20, 2024
Via
Investor Brand Network
12 Health Care Stocks Moving In Tuesday's After-Market Session
March 19, 2024
Via
Benzinga
Study Links Parkinson’s Onset in Rocky Mountain Area to Agricultural Pesticides
March 01, 2024
Via
Investor Brand Network
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Reports on Year-End 2023 Financial Results, Corporate Update
February 28, 2024
Via
Investor Brand Network
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Announces Plans to Release Year-End 2023 Financial Results, Corporate Update
February 22, 2024
Via
Investor Brand Network
BioMedNewsBreaks — Longeveron Inc.’s (NASDAQ: LGVN) ELPIS Trial Demonstrates Potential Survival Benefit of Lomecel-B(TM) for HLHS Patients
February 21, 2024
Via
Investor Brand Network
Study Links Ramadan Fasting to Lower Risk of Chronic Disease Development
February 14, 2024
Via
Investor Brand Network
BioRestorative Therapies Presents Promising Data At Orthopaedic Research Society (ORS) 2024 Annual Meeting
February 13, 2024
BioRestorative Therapies (NASDAQ: BRTX) is a clinical-stage biotech company that is developing cell-based therapies to treat chronic lumbar disc disease and metabolic conditions such as obesity and...
Via
Benzinga
Longeveron (NASDAQ: LGVN) Making Inroads With Lomecel-B™ – Biotech’s Investigational Alzheimer’s Treatment Shows Positive Trial Results
February 08, 2024
--News Direct--
Via
News Direct
Longeveron (NASDAQ: LGVN) Making Inroads With Lomecel-B™ – Biotech's Investigational Alzheimer's Treatment Shows Positive Trial Results
February 07, 2024
Longeveron Inc. (NASDAQ: LGVN), a clinical-stage biotech company aiming to slow the effects of life-threatening and chronic aging-related conditions using cellular therapies, is making inroads with...
Via
Benzinga
Longeveron Inc.’s (NASDAQ: LGVN) Long-Term Follow-Up Data from Its ELPIS I Clinical Trial Presented at the 2023 Annual Scientific Sessions of the American Heart Association
February 07, 2024
Via
Investor Brand Network
BioMedNewsBreaks – H.C. Wainwright & Co. Reiterates ‘Buy’ Rating, $6 PT on Longeveron (NASDAQ: LGVN)
February 06, 2024
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
Dietician Tips for Boosting Muscle Mass, Living Longer
January 31, 2024
Via
Investor Brand Network
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 31, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
January 30, 2024
Via
Benzinga
BioMedNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Granted US Patent Allowance for Key Technology Behind Lead Investigation Product
January 29, 2024
Via
Investor Brand Network
Topics
Intellectual Property
Exposures
COVID-19
Intellectual Property
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 29, 2024
Via
Benzinga
Scientists Discover Alzheimer’s Can Be Categorized into Five Subtypes
January 18, 2024
Via
Investor Brand Network
Lineage Cell Therapeutics, Longeveron And 2 Other Stocks Under $2 Insiders Are Buying
January 03, 2024
The Dow Jones index closed higher by around 25 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
< Previous
1
2
3
4
5
6
7
8
9
...
15
16
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.